Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | CMGC family protein kinase | 0.0051 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0081 | 0.9303 | 1 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription factor | 0.0083 | 1 | 1 |
Leishmania major | mitogen activated protein kinase, putative,map kinase, putative | 0.0051 | 0 | 0.5 |
Trypanosoma brucei | protein kinase, putative | 0.0051 | 0 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0068 | 0.5236 | 1 |
Leishmania major | mitogen activated protein kinase 4, putative;with=GeneDB:LmxM19.1440 | 0.0051 | 0 | 0.5 |
Trypanosoma cruzi | mitogen activated protein kinase 2, putative | 0.0051 | 0 | 0.5 |
Trypanosoma brucei | mitogen activated protein kinase 4, putative | 0.0051 | 0 | 0.5 |
Toxoplasma gondii | CMGC kinase, MAPK family (ERK) MAPK-1 | 0.0051 | 0 | 0.5 |
Onchocerca volvulus | 0.0065 | 0.4539 | 0.5 | |
Schistosoma mansoni | jun-related protein | 0.0068 | 0.5236 | 1 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0051 | 0 | 0.5 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription factor | 0.0083 | 1 | 1 |
Trypanosoma cruzi | mitogen-activated protein kinase 11, putative | 0.0051 | 0 | 0.5 |
Giardia lamblia | Kinase, CMGC MAPK | 0.0051 | 0 | 0.5 |
Trypanosoma cruzi | mitogen-activated protein kinase 11, putative | 0.0051 | 0 | 0.5 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0051 | 0 | 0.5 |
Echinococcus granulosus | jun protein | 0.0083 | 1 | 1 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0051 | 0 | 0.5 |
Echinococcus multilocularis | jun protein | 0.0083 | 1 | 1 |
Brugia malayi | hypothetical protein | 0.0065 | 0.4539 | 0.4539 |
Trypanosoma cruzi | mitogen activated protein kinase 4, putative | 0.0051 | 0 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.